SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013582
Filing Date
2023-05-10
Accepted
2023-05-10 16:05:46
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20230331_10q.htm   iXBRL 10-Q 536386
2 EXHIBIT 31.1 ex_468529.htm EX-31.1 13417
3 EXHIBIT 31.2 ex_468530.htm EX-31.2 13250
4 EXHIBIT 32.1 ex_468531.htm EX-32.1 6692
5 EXHIBIT 32.2 ex_468532.htm EX-32.2 6771
11 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-23-013582.txt   2973268

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230331.xsd EX-101.SCH 33190
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20230331_cal.xml EX-101.CAL 23746
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230331_def.xml EX-101.DEF 211388
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230331_lab.xml EX-101.LAB 182576
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230331_pre.xml EX-101.PRE 225767
42 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230331_10q_htm.xml XML 327724
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 23906301
SIC: 2834 Pharmaceutical Preparations